SELKIRK PHARMA, INC. — Form D
SELKIRK PHARMA, INC. of SPOKANE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-13. The offering totals $25.0M, of which $24.1M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2023-09-13
- Form: D
- Accession: 0001732446-23-000001
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $24.1M
- Remaining: $897K
- Investors: 114
- Date of first sale: 2023-08-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492049
Issuer
- Name: SELKIRK PHARMA, INC.
- CIK: 0001732446
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2017
- Address: 9110 W GRANITE AVE, SPOKANE, WA, 99224
- Phone: 509-340-9909
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| MARSHALL CREW | Director | SPOKANE, WA |
| PATRICK HAFFEY | Director | SPOKANE, WA |
| JOE HERZOG | Director | New York, NY |
| ROD RAABE | Director | Santa Rosa, CA |
| TOM TOBIN | Director | SPOKANE, WA |
| PATRICK HAFFEY | Executive Officer | SPOKANE, WA |
| JOE HERZOG | Executive Officer | New York, NY |
Other filings by this issuer (4)
More